
GC41716
(R)-CR8
Also known as (2R)-2-[[9-propan-2-yl-6-[(4-pyridin-2-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol
Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy
ChemicalCAS294646-77-8MW431.5FormulaC24H29N7O
- CAS number
- 294646-77-8
- Molecular weight
- 431.5
- Formula
- C24H29N7O
- Solubility
- DMSO : 50 mg/mL (115·87 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- HOCBJBNQIQQQGT-LJQANCHMSA-N
- Catalogue number
- GC41716
- Brand
- GLPBIO
Computed properties PubChem CID 10224714 · XLogP 3.8 · TPSA 101 Ų · H-bond donors 3
- XLogP
- 3.8
- TPSA
- 101 Ų
- H-bond donors
- 3
- H-bond acceptors
- 7
- Rotatable bonds
- 9
- Heavy atoms
- 32
SMILES CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=C(C=C3)C4=CC=CC=N4
Computed descriptors from PubChem (CID 10224714), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il